---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-065563"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2022-10-21T23:59:59+00:00"
generated_at: "2026-06-23T02:01:29.911528+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# HSAC2 amends backstop and forward purchase agreements with RTW Funds for Orchestra deal

## Summary
- Per-share purchase price under both agreements capped at the shareholder redemption price (not exceeding $10.00).
- RTW Funds agree not to vote shares purchased under these agreements in favor of the business combination.
- RTW Funds waive redemption rights for those shares in connection with the vote to approve the combination.
- Amendments executed on October 21, 2022, modifying the July 4, 2022 agreements.

## SEC filing metadata
- accession: 0001213900-22-065563
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2022-10-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390022065563/0001213900-22-065563-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390022065563/ea167391-8k425_health.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-065563
- JSON: https://secwatch.observer/filing/0001213900-22-065563.json
- Plain text: https://secwatch.observer/filing/0001213900-22-065563.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.